PubMed · 3624494
A solid-phase receptor binding assay for 125I-hCG.
Abstract
A solid-phase radioligand-receptor assay (RRA) to measure the binding of 125I-labelled human chorionic gonadotropin (125I-hCG) to target cell membranes has been developed. The binding of 125I-hCG to membranes immobilized on the wells of microtitration plates reached a maximum at about 3 hours at 37 degrees C, was saturable, displayed a high affinity (Ka = 2.4 X 10(9) M-1) and was specifically inhibited by unlabelled hCG. In comparison with RRAs carried out with membranes in suspension, the solid-phase RRA is significantly simpler and much faster to perform as it avoids centrifugation or filtration procedures. The solid-phase RRA was adapted profitably to process large numbers of samples at the same time. It proved particularly useful as a screening assay to detect anti-hCG monoclonal antibodies with high inhibitory activity for binding of 125I-hCG to its receptors.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M Bortolussi, O Selmin, A Colombatti. 1987. A solid-phase receptor binding assay for 125I-hCG.. https://doi.org/10.1080/15321818708057023
Cite the original work for its findings. Save a collection to share your selection of sources.